Cited by 526Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis MechanismsAcute Ischemic Stroke Management

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

Ginsburg, Katherine S., Liang, Matthew H., Newcomer, Laura, Goldhaber, Samuel Z., Schur, Peter H., Hennekens, Charles H., Stampfer, Meir J.·1992·Annals of Internal Medicine

DOI 10.7326/0003-4819-117-12-997

Open this paper in CoChat — free account

Abstract

Objective To determine whether the presence of anticardiolipin antibodies is a risk factor for ischemic stroke and venous thrombosis in healthy adult men. Design A nested, case-control study in a prospective cohort. Setting A nationwide study of physicians. Participants The study sample was drawn from the Physicians' Health Study, a randomized, double-blind, placebo-controlled trial of aspirin and beta-carotene in 22,071 male physicians. At entry, 68% of the participants submitted plasma samples that were subsequently frozen at -80 degrees C. During 60.2 months of follow-up, follow-up for nonfatal outcomes was 99.7% complete and ascertainment of fatal outcomes was 100% complete. We identified men with documented ischemic stroke, deep venous thrombosis of the leg, or pulmonary embolus and for whom a plasma sample was available. A control was matched by age, smoking history, and length of follow-up to each of the 100 patients with ischemic stroke and the 90 patients with deep venous thrombosis or pulmonary embolus. Measurements Plasma samples were assessed for IgG anticardiolipin antibodies by enzyme-linked immunosorbent assay. The mean anticardiolipin antibody titers of the case patients in the two diagnostic groups (ischemic stroke; venous thrombosis or pulmonary embolus) were compared with those of the control groups, and relative risks were calculated for patients in increasing percentile categories of anticardiolipin antibodies by conditional logistic regression. Results T…

Integrity signals

Registry

Crossref · 10.7326/0003-4819-117-12-997

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
The “Primary” Antiphospholipid Syndrome
Asherson, R. A., Khamashta, M. A., Ordi, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 963
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients
Alarcón-Segovia, D., Delezé, M., Oria, C. V., Sánchez‐Guerrero, J., Gómez-Pacheco, L., Cabiedes, J., Fernández, L. A. N., & de León, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 635
ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATION
Carreras, L., Machin, S. J., Deman, R., DEFREYN, G., Vermylen, J., Spitz, B., & Assche, A. V. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92087-0 · Cited by 551
Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.
Loizou, S., McCrea, J. D., Rudge, A. C., Reynolds, R., Boyle, C. C., & Harris, E. N. (1985) · PubMed Central · Cited by 549
Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia
Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 546
Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health Study
The Steering Committee of the Physicians' Health Study Research Group (1988) · New England Journal of Medicine · doi:10.1056/nejm198801283180431 · Cited by 522
Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant
Boey, M. L., Colaco, C. B., Gharavi, A. E., Elkon, K. B., Loizou, S., & Hughes, G. R. (1983) · BMJ · doi:10.1136/bmj.287.6398.1021 · Cited by 508
ANTIBODIES TO CARDIOLIPIN IN YOUNG SURVIVORS OF MYOCARDIAL INFARCTION: AN ASSOCIATION WITH RECURRENT CARDIOVASCULAR EVENTS
Hamsten, A., Björkholm, M., Norberg, R., Fairé, U. D., & Holm, G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92258-0 · Cited by 356
Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease
Gerstman, B. B., Piper, J. M., Tomita, D. K., Ferguson, W., Stadel, B. V., & Lundin, F. E. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115799 · Cited by 349
Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome
Asherson, R. A., Khamashta, M. A., Gil, A., Vázquez, J. P. F., Chan, O., Baguley, E., & Hughes, G. R. V. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90335-5 · Cited by 328
The Spectrum of Neurologic Disease Associated With Antiphospholipid Antibodies
Levine, S. R. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520200078024 · Cited by 301
Cigarette Smoking and Risk of Stroke in Middle-Aged Women
Colditz, G. A., Bonita, R., Stampfer, M. J., Willett, W. C., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804143181501 · Cited by 297
Self-citation
Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.
Khamashta, M. A., Harris, E. N., Gharavi, A. E., Derue, G., Gil, A., Vázquez, J. J., & Hughes, G. R. V. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.10.849 · Cited by 226
Antiphospholipid antibody syndrome: Immunologic and clinical aspects
Sammaritano, L. R., Gharavi, A. E., & Lockshin, M. D. (1990) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(90)90021-7 · Cited by 193
Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies.
Lavalle, C. M., Pizarro, S., Drenkard, C., Sánchez‐Guerrero, J., & Alarcón-Segovia, D. (1990) · PubMed · Cited by 185
Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.
Asherson, R. A., Mercey, D., Phillips, G., Sheehan, N. J., Gharavi, A. E., Harris, E. N., & Hughes, G. R. V. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.8.605 · Cited by 166
Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the ‘primary’ antiphospholipid syndrome.
Asherson, R. A., Merry, P., Acheson, J. F., Harris, E. N., & Hughes, G. R. V. (1989) · Annals of the Rheumatic Diseases · doi:10.1136/ard.48.5.358 · Cited by 159
Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus
KALUNIAN, K. C., Middlekauff, H. R., Sayre, J. A., Ando, D. G., Mangotich, M., Hahn, B. H., & Peter, J. B. (1988) · The American Journal of Medicine · doi:10.1016/s0002-9343(88)80229-8 · Cited by 150
Antiphospholipid Anti-Bodies—Autoantibodies with a Difference
Harris, E. N., Asherson, R. A., & Hughes, G. R. V. (1988) · Annual Review of Medicine · doi:10.1146/annurev.me.39.020188.001401 · Cited by 146
CORONARY ARTERY BYPASS GRAFT FAILURE—AN AUTOIMMUNE PHENOMENON?
Morton, K., Krilis, S. A., Baron, D., Gavaghan, T. P., Daggard, G. E., Jb, H., & Chesterman, C. N. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92004-0 · Cited by 146
Crossreactivity of antiphospholipid antibodies.
Harris, E. N., Gharavi, A. E., Loizou, S., Derue, G., Chan, J. K., Patel, B. M., Mackworth-Young, C. G., Bunn, C. C., & Hughes, G. R. V. (1985) · PubMed · Cited by 144
Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity.
Colaco, C. B., & Male, D. K. (1985) · PubMed · Cited by 133
Risk factors in pulmonary embolism.
Ww, C. (1976) · PubMed · Cited by 131
Risk factors for stroke in patients with nonrheumatic atrial fibrillation: A case-control study
Moulton, A. W., Singer, D. E., & Haas, J. S. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90008-l · Cited by 130
Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke
Sletnes, K. E., Wislöff, F., Smith, P., Arnesen, H., & Abdelnoor, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91057-f · Cited by 128
Anticardiolipin antibodies in patients with rheumatic diseases
Fort, J. G., Cowchock, F. S., Abruzzo, J. L., & Smith, J. B. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300705 · Cited by 128
Anticardiolipin antibodies in patients with systemic lupus erythematosus
Sturfelt, G. K., Nived, O., Norberg, R., Thorstensson, R., & Krook, K. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300404 · Cited by 124
Screening for hypercoagulable states in vascular surgical practice: A preliminary study
Donaldson, M. C., Weinberg, D. S., Belkin, M., Whittemore, A. D., & Mannick, J. A. (1990) · Journal of Vascular Surgery · doi:10.1016/0741-5214(90)90080-t · Cited by 102
Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant
Pope, J. M., Canny, C. L. B., & Bell, D. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80009-b · Cited by 85
Myocardial Infarction and Antiphospholipid Antibodies in SLE and Related Disorders
Asherson, R. A., Khamashta, M. A., Baguley, E., Oakley, C. M., Rowell, N., & Hughes, G. R. V. (1989) · QJM · doi:10.1093/oxfordjournals.qjmed.a068400 · Cited by 84
IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes.
Cronin, M. E., Biswas, R. M., der Straeton, C. V., Fleisher, T., & Klippel, J. H. (1988) · PubMed · Cited by 82
Occlusive retinal vascular disease in systemic lupus erythematosus.
Hall, S., Buettner, H., & Luthra, H. S. (1984) · PubMed · Cited by 80
Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin.
Ruiz-Argüelles, G. J., Ruı́z-Argüelles, A., Delezé, M., & Alarcón-Segovia, D. (1989) · PubMed · Cited by 73
Anti-cardiolipin antibodies in ischaemic heart disease.
Klemp, P., Cooper, R., Strauss, F. J., Jordaan, E., Przybojewski, J. Z., & Nel, N. (1988) · PubMed Central · Cited by 69
Discordant effects of prednisone on anticardiolipin antibodies and the lupus anticoagulant
Derksen, R. H. W. M., Biesma, D. H., Bouma, B. N., Gmelig-Meyling, F. H. J., & Kater, L. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291021 · Cited by 68
The Relationship of Anti-DNA Antibody Idiotypes and Anti-Cardiolipin Antibodies to Disease Activity in Systemic Lupus Erythematosus
Isenberg, D. A., Colaco, C. B., Dudeney, C., Todd-Pokropek, A. E., & Snaith, M. L. (1986) · Medicine · doi:10.1097/00005792-198601000-00003 · Cited by 59
Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study.
Out, H. J., de Groot, P. G., Hasselaar, P., van Vliet, M., & Derksen, R. H. W. M. (1989) · Annals of the Rheumatic Diseases · doi:10.1136/ard.48.12.1023 · Cited by 59
Antiphospholipid antibodies, prethrombotic states, and stroke.
Coull, B. M., & Goodnight, S. H. (1990) · Stroke · doi:10.1161/01.str.21.9.1370 · Cited by 53
Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia.
Kushner, M., & Simonian, N. (1989) · Stroke · doi:10.1161/01.str.20.2.225 · Cited by 51
Prevalence of anticardiolipin antibodies in coronary artery disease
Caterina, R. D., d’Ascanio, A., Mazzone, A., Gazzetti, P., Bernini, W., Neri, R., & Bombardieri, S. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91439-d · Cited by 43
Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE.
Meyer, O., Pietté, J. C., Bourgeois, P., Fallas, P., Blétry, O., Jungers, P., Mf, K., Godeau, P., & Ryckewaert, A. (1987) · PubMed · Cited by 43
Aortic occlusion in systemic lupus erythematosus associated with antiphospholipid antibodies.
Drew, P., Asherson, R. A., Zuk, R. J., Goodwin, F. J., & Hughes, G. R. V. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.8.612 · Cited by 34
Myocardial infarction in systemic lupus erythematosus and “lupus‐like” disease
Asherson, R. A., Harris, N. E., Gharavi, A. E., & Hughes, G. R. V. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291019 · Cited by 30
Antiphospholipid antibody and antiphospholipid antibody syndrome
Lockshin, M. D. (1991) · Current Opinion in Rheumatology · doi:10.1097/00002281-199110000-00008 · Cited by 26
THE RELATIONSHIP OF ANTICARDIOLIPIN ANTIBODIES TO DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Cooper, R., Klempt, P., STIPP, C. J., & BRINK, S. (1989) · Lara D. Veeken · doi:10.1093/rheumatology/28.5.379 · Cited by 16

Research works printed but not linked: 15

Meyer O, 1987, J Rheum., 14, 502
Colaco C, 1983, Ann Rheum Dis., 42, 228
Harris E, 1985, J Clin Lab Immunol., 16, 1
Colaco C, 1985, Clin Exp Immunol., 59, 449
Harris E, 1987, Clin Exp Immunol., 68, 215
Hall S, 1984, J Rheum., 11, 846
Asherson R, 1989, Q J Med., 73, 1103
Cronin M, 1988, J Rheum., 15, 795
Klemp P, 1988, Clin Exp Immunol., 74, 254
Lavalle C, 1990, J Rheum., 17, 34
Coon W, 1976, Surg Gynecol Obstet., 143, 385
Hasselaar P, 1990, J Rheumatol., 17, 186
Loizou S, 1985, Clin Exp Immunol., 62, 738
Ruiz-Arguelles G, 1989, J Rheumatol., 16, 381
McNeil H, 1990, Clin Exp Rheumatol., 8, 525

Sorted by citations

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,368
Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Risk Factors for Venous Thromboembolism
Anderson, F. A., & Spencer, F. A. (2003) · Circulation · doi:10.1161/01.cir.0000078469.07362.e6 · Cited by 1,732
The Antiphospholipid Syndrome
Levine, J. S., Branch, D. W., & Rauch, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra002974 · Cited by 1,524

See all 526

Authors: Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Liang, Matthew H.
Goldhaber, Samuel Z.
Hennekens, Charles H.
Stampfer, Meir J.
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 1992-12-15
Volume: 117
Issue: 12
Pages: 997-1002
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-117-12-997
OpenAlex: W1491481195
Cited by: 526
References: 49
Citations by year: 2025: 2 · 2024: 7 · 2023: 5 · 2022: 1 · 2021: 8 · 2020: 8 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 7 · 2014: 10 · 2013: 15 · 2012: 16
FWCI: 16.25
Type: journal article
Language: en
Open access: closed
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (R01CA042182, CA 42182)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60AR036308, AR-36308, AR-07530, T32AR007530)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords: anticardiolipin antibodies, ischemic stroke, venous thrombosis, deep vein thrombosis, pulmonary embolism, thrombophilia, risk factors, IgG, male physicians, Physicians' Health Study, aspirin, beta-carotene, anticoagulation, stroke prevention, antithrombotic therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Brain Ischemia, Enzyme-Linked Immunosorbent Assay, Humans, Male, Middle Aged, Prospective Studies, Pulmonary Embolism, Risk Factors, Statistics as Topic, Thrombophlebitis, Case-Control Studies, Antibodies, Anticardiolipin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks